MSF

MSF

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • Patients left vulnerable as diabetes supplies dwindle

    Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa’s public healthcare system, but the setbacks keep coming. While some communities are facing shortages of blood sugar meters and insulin pens, a smaller wave of insulin vial shortages is now on the horizon, reports Joan van Dyk.

    ·

  • Competition law has again worked to fight a bad drug patent, but we need other solutions

    A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and…

    ·

  • “Someone had to do it”, says SA TB activist on Time 100 list

    At the age of 19 Phumeza Tisile contracted multidrug-resistant tuberculosis. For four years she battled the disease, losing her hearing in the process. At one stage, a doctor told her to visit a priest and prepare her soul for death. Recently, Tisile (now 33) made it on to TIME magazine’s 2023 TIME100 Next list, as…

    ·

  • “The situation is not going away,” says inspiring TB doctor

    Dr Juli Switala (42) has treated children in Nigeria, helped fatally ill patients during the 2014 Ebola outbreak in Sierra Leone, and delivered babies at a hospital in Afghanistan against a backdrop of upheaval and violence. But nowhere cuts close to her heart quite like Brooklyn Chest – the tuberculosis (TB) hospital on Cape Town’s…

    ·

  • This court case will literally determine whether some people get to breathe

    A pivotal case for access to affordable medicines in South Africa is set to determine whether people in South Africa will be able to get access to breakthrough cystic fibrosis treatments. Aneesa Adams spent some time with a family living with cystic fibrosis to get a sense of what is at stake.

    ·

  • Struggle for migrant health rights still far from over after landmark judgment 

    In a landmark court decision, the Gauteng High Court recently confirmed the rights of all pregnant and lactating women and children under age six to access services for free at all levels of care. The court order sets a good precedent for migrant health rights going forward, writes Mbali Baduza and Kholofelo Mphahlele as they…

    ·

  • Supply issues delaying wider rollout of shorter TB preventive therapy

    South Africa’s recently published guidelines for the treatment of tuberculosis (TB) infection have been welcomed by several experts. Among others, the guidelines endorse the use of a three-month course of TB preventive therapy as opposed to the old six-month course. But, while the intention is to roll out the three-month course quite widely, supply constraints…

    ·

  • “It took me three seconds to decide” – Fareed Abdullah reflects on his career in public health

    Over the last three decades, Dr Fareed Abdullah has been at the coalface of South Africa’s response to HIV, tuberculosis, and more recently, COVID-19. Biénne Huisman chatted with Abdullah about providing antiretrovirals in the time of AIDS denialism, National Health Insurance, working as a medical doctor, and the toll HIV has sadly taken on his…

    ·

  • Are youth-only clinics the answer to better healthcare for young people?

    Special youth clinics appear to be an effective means of providing healthcare services to young people who otherwise might not engage with healthcare services. But is building more youth clinics realistic given our resource constraints, or is it better to focus on making ‘normal’ clinics more youth-friendly – or should we be looking beyond clinic-based…

    ·

  • Shorter, simpler DR-TB regimen expected later this year

    A new six-month treatment regimen for drug-resistant forms of tuberculosis is expected to be rolled out in the public sector later this year – current regimens take anything from nine to 18 months. Catherine Tomlinson unpacks why the switch is important and outlines what still needs to happen to make it a reality.

    ·

  • ‘I view the doctor-patient relationship as sacred’ – Dr Jennifer Furin

    Dr Jennifer Furin has fought drug-resistant tuberculosis (TB) since 1995, when she worked as a student in a poverty-stricken suburb in Lima, Peru. Since then she has roamed the world, treating TB and HIV patients in under-resourced countries, including Haiti, Russia, Tajikistan, Bangladesh, eSwatini, Lesotho, and South Africa. Biénne Huisman chatted to Furin about her…

    ·

  • New licenses could spark manufacture of COVID-19 pills in Africa

    Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the…

    ·